Funds holding BioNTech SE
ISIN US09075V1026 · Germany · LEI 894500UZJ5LG1F8J1U58
- Fund holders
- 142
- Of which ETFs
- 30 112 other funds
- Value held
- ≈ 1.7B $ 1.7B $ · 287.9M SEK · 1.1M €
142 funds hold this company. This table lists the 137 that declare it in a regulatory filing. The other 5 publish their holdings in their own reports. The “Fund reports” tab lists them, with their weight.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Contrafund Fidelity Contrafund | 3,278,252 | 305M $ | 0.17 % | as of Jun 30, 2026 ↗ |
| Dodge & Cox International Stock Fund Dodge & Cox Funds | 2,517,713 | 234.3M $ | 0.35 % | as of Jun 30, 2026 ↗ |
| VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS | 2,189,120 | 203.7M $ | 0.62 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 1,018,613 | 94.8M $ | 0.41 % | as of Jun 30, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 897,156 | 81.3M $ | 1.10 % | as of Jul 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 794,727 | 73.9M $ | 2.63 % | as of Jun 30, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 704,487 | 65.6M $ | 0.17 % | as of Jun 30, 2026 ↗ |
| Fidelity Emerging Markets Fund Fidelity Investment Trust | 660,800 | 59.9M $ | 0.55 % | as of Jul 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 647,133 | 60.2M $ | 0.66 % | as of Jun 30, 2026 ↗ |
| Dodge & Cox Global Stock Fund Dodge & Cox Funds | 525,778 | 48.9M $ | 0.38 % | as of Jun 30, 2026 ↗ |
| MFS Mid Cap Value Fund MFS SERIES TRUST XI | 487,157 | 45.3M $ | 0.26 % | as of Jun 30, 2026 ↗ |
| PRIMECAP Odyssey Growth Fund PRIMECAP Odyssey Funds | 354,600 | 32.1M $ | 0.53 % | as of Jul 31, 2026 ↗ |
| Strategic Advisers Fidelity Emerging Markets Fund Fidelity Rutland Square Trust II | 244,800 | 23.5M $ | 0.06 % | as of May 31, 2026 ↗ |
| Fidelity Value Fund Fidelity Capital Trust | 200,000 | 18.1M $ | 0.17 % | as of Jul 31, 2026 ↗ |
| Schwab Fundamental International Equity ETF SCHWAB STRATEGIC TRUST | 196,561 | 18.9M $ | 0.08 % | as of May 31, 2026 ↗ |
| SEB Läkemedelsfond SEB Funds AB | 170,060 | 144M SEK | 0.89 % | as of Mar 31, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 163,253 | 15.7M $ | 1.04 % | as of May 31, 2026 ↗ |
| Nomura International Core Equity Fund IVY FUNDS | 135,880 | 12.6M $ | 0.92 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 126,600 | 11.8M $ | 0.10 % | as of Jun 30, 2026 ↗ |
| VIP Mid Cap Portfolio Variable Insurance Products Fund III | 118,800 | 11.1M $ | 0.12 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 115,335 | 10.7M $ | 0.42 % | as of Jun 30, 2026 ↗ |
| Franklin International Growth Fund Franklin Global Trust | 106,400 | 9.6M $ | 1.60 % | as of Jul 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 100,001 | 9.6M $ | 0.01 % | as of May 31, 2026 ↗ |
| International Equity Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 99,000 | 9.2M $ | 0.36 % | as of Jun 30, 2026 ↗ |
| Fidelity New Millennium Fund Fidelity Mt. Vernon Street Trust | 96,500 | 9.3M $ | 0.16 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF SPDR INDEX SHARES FUNDS | 96,348 | 9M $ | 0.02 % | as of Jun 30, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 90,795 | 8.4M $ | 0.41 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 86,530 | 8.1M $ | 0.08 % | as of Jun 30, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 83,637 | 7.8M $ | 0.31 % | as of Jun 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 82,542 | 7.7M $ | 1.94 % | as of Jun 30, 2026 ↗ |
| Nomura VIP International Core Equity Series Ivy Variable Insurance Portfolios | 76,455 | 7.1M $ | 0.93 % | as of Jun 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 73,400 | 6.6M $ | 0.58 % | as of Jul 31, 2026 ↗ |
| JPMorgan BetaBuilders Europe ETF J.P. Morgan Exchange-Traded Fund Trust | 72,970 | 6.6M $ | 0.07 % | as of Jul 31, 2026 ↗ |
| Strategic Advisers Emerging Markets Fund Fidelity Rutland Square Trust II | 72,600 | 7M $ | 0.04 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 69,017 | 6.6M $ | 0.02 % | as of May 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 64,900 | 6.2M $ | 0.12 % | as of May 31, 2026 ↗ |
| Baillie Gifford International Alpha Fund Baillie Gifford Funds | 62,122 | 5.8M $ | 0.34 % | as of Jun 30, 2026 ↗ |
| Invesco NASDAQ Next Gen 100 ETF Invesco Exchange-Traded Fund Trust II | 58,878 | 5.6M $ | 0.51 % | as of May 31, 2026 ↗ |
| JNL/MFS Mid Cap Value Fund JNL Series Trust | 55,701 | 5.2M $ | 0.26 % | as of Jun 30, 2026 ↗ |
| Fidelity Mid Cap Value Fund Fidelity Devonshire Trust | 55,052 | 5M $ | 0.21 % | as of Jul 31, 2026 ↗ |
| Large-Cap Growth Portfolio PACIFIC SELECT FUND | 53,528 | 5M $ | 0.34 % | as of Jun 30, 2026 ↗ |
| Baillie Gifford International Stock Portfolio Brighthouse Funds Trust II | 48,670 | 4.5M $ | 0.35 % | as of Jun 30, 2026 ↗ |
| Fidelity Advisor Value Strategies Fund Fidelity Advisor Series I | 47,600 | 4.6M $ | 0.21 % | as of May 31, 2026 ↗ |
| T. Rowe Price Mid Cap Growth Portfolio Brighthouse Funds Trust I | 47,320 | 4.4M $ | 0.39 % | as of Jun 30, 2026 ↗ |
| Swedbank Robur Healthcare Swedbank Robur Fonder AB | 46,200 | 39.1M SEK | 0.28 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 41,921 | 4M $ | 0.07 % | as of May 29, 2026 ↗ |
| Schwab Fundamental International Equity Index Fund SCHWAB CAPITAL TRUST | 38,329 | 3.5M $ | 0.06 % | as of Jul 31, 2026 ↗ |
| Fidelity Blue Chip Value Fund Fidelity Securities Fund | 37,300 | 3.4M $ | 0.47 % | as of Jul 31, 2026 ↗ |
| Handelsbanken Global Index Criteria Handelsbanken Fonder AB | 36,983 | 30.8M SEK | 0.02 % | as of Mar 31, 2026 ↗ |
| JPMorgan BetaBuilders International Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 32,899 | 3M $ | 0.05 % | as of Jul 31, 2026 ↗ |
| Handelsbanken Europa Index Criteria Handelsbanken Fonder AB | 30,995 | 25.8M SEK | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO International Index Fund Fidelity Concord Street Trust | 30,071 | 2.7M $ | 0.02 % | as of Jul 31, 2026 ↗ |
| Fidelity Advisor Mid Cap II Fund Fidelity Advisor Series I | 29,300 | 2.7M $ | 0.12 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 28,414 | 2.7M $ | 0.03 % | as of May 31, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Multi-Asset Fund | 27,232 | 2.5M $ | 0.17 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF SPDR SERIES TRUST | 25,847 | 2.4M $ | 0.08 % | as of Jun 30, 2026 ↗ |
| VIP Value Strategies Portfolio Variable Insurance Products Fund III | 24,100 | 2.2M $ | 0.18 % | as of Jun 30, 2026 ↗ |
| Hartford Global Impact Fund HARTFORD MUTUAL FUNDS, INC | 21,576 | 2M $ | 0.55 % | as of Jul 31, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 21,315 | 1.9M $ | 0.57 % | as of Jul 31, 2026 ↗ |
| Invesco RAFI Developed Markets ex-U.S. ETF Invesco Exchange-Traded Fund Trust II | 20,996 | 1.9M $ | 0.07 % | as of Jul 31, 2026 ↗ |
| SEB Europafond SEB Funds AB | 20,000 | 17.1M SEK | 0.60 % | as of Mar 31, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 19,841 | 1.9M $ | 3.41 % | as of May 31, 2026 ↗ |
| Handelsbanken Developed Markets Index Criteria Handelsbanken Fonder AB | 19,194 | 16M SEK | 0.03 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 19,180 | 1.8M $ | 0.41 % | as of Jun 30, 2026 ↗ |
| Multi-Manager International Equity Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 19,047 | 1.8M $ | 0.06 % | as of May 31, 2026 ↗ |
| MFS Mid Cap Value Portfolio MFS VARIABLE INSURANCE TRUST III | 18,074 | 1.7M $ | 0.26 % | as of Jun 30, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 18,000 | 1.7M $ | 0.22 % | as of Jun 30, 2026 ↗ |
| Optimum International Fund Optimum Fund Trust | 17,618 | 1.6M $ | 0.14 % | as of Jun 30, 2026 ↗ |
| MML VIP T. Rowe Price Mid Cap Growth Fund MML SERIES INVESTMENT FUND | 17,446 | 1.6M $ | 0.40 % | as of Jun 30, 2026 ↗ |
| Biotechnology Fund Rydex Series Funds | 17,055 | 1.6M $ | 1.16 % | as of Jun 30, 2026 ↗ |
| JNL International Index Fund JNL Series Trust | 15,497 | 1.4M $ | 0.05 % | as of Jun 30, 2026 ↗ |
| Capital Appreciation Value Fund John Hancock Funds II | 15,097 | 1.4M $ | 0.10 % | as of May 31, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 14,989 | 1.4M $ | 1.38 % | as of Jul 31, 2026 ↗ |
| Franklin Mutual Small-Mid Cap Value Fund Franklin Value Investors Trust | 13,469 | 1.2M $ | 0.53 % | as of Jul 31, 2026 ↗ |
| UBS International Sustainable Equity Fund UBS FUNDS | 11,164 | 1M $ | 0.87 % | as of Jun 30, 2026 ↗ |
| Fidelity Flex International Index Fund Fidelity Salem Street Trust | 10,627 | 962.6K $ | 0.02 % | as of Jul 31, 2026 ↗ |
| SEB European Defence & Security Fund SEB Funds AB | 9,349 | 7.9M SEK | 0.51 % | as of Mar 31, 2026 ↗ |
| AVIP Fidelity Institutional AM Equity Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 9,259 | 861.5K $ | 0.35 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 7,900 | 735.1K $ | 0.10 % | as of Jun 30, 2026 ↗ |
| Fidelity Advisor Value Fund Fidelity Advisor Series I | 7,391 | 669.5K $ | 0.17 % | as of Jul 31, 2026 ↗ |
| AXS Green Alpha ETF INVESTMENT MANAGERS SERIES TRUST II | 7,343 | 683.3K $ | 1.19 % | as of Jun 30, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 6,266 | 583.1K $ | 1.25 % | as of Jun 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 6,112 | 586.4K $ | 0.87 % | as of May 31, 2026 ↗ |
| Guardian Large Cap Fundamental Growth VIP Fund Guardian Variable Products Trust | 6,024 | 560.5K $ | 0.35 % | as of Jun 30, 2026 ↗ |
| Fidelity Mid Cap Value K6 Fund Fidelity Devonshire Trust | 5,508 | 498.9K $ | 0.21 % | as of Jul 31, 2026 ↗ |
| Goldman Sachs Innovate Equity ETF Goldman Sachs ETF Trust | 5,435 | 521.5K $ | 0.25 % | as of May 31, 2026 ↗ |
| BNY Mellon International Equity ETF BNY Mellon ETF Trust | 5,344 | 486K $ | 0.04 % | as of Jul 31, 2026 ↗ |
| BlackRock Balanced Fund, Inc. BlackRock Balanced Fund, Inc. | 4,975 | 477.4K $ | 0.03 % | as of May 29, 2026 ↗ |
| Goldman Sachs MarketBeta International Equity ETF Goldman Sachs ETF Trust | 4,939 | 472.3K $ | 0.05 % | as of May 31, 2026 ↗ |
| Calvert International Responsible Index Fund Calvert Responsible Index Series, Inc. | 4,826 | 449.1K $ | 0.03 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 4,213 | 404.2K $ | 0.55 % | as of May 31, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 4,156 | 386.7K $ | 1.38 % | as of Jun 30, 2026 ↗ |
| Lysa Global Equity Focus Lysa Fonder AB | 4,035 | 3.4M SEK | 0.06 % | as of Mar 31, 2026 ↗ |
| VIP International Index Portfolio Variable Insurance Products Fund II | 3,609 | 335.8K $ | 0.02 % | as of Jun 30, 2026 ↗ |
| PROFUND VP EUROPE 30 ProFunds | 3,340 | 310.8K $ | 1.85 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 3,188 | 296.6K $ | 1.29 % | as of Jun 30, 2026 ↗ |
| Lysa Global Equity Broad Lysa Fonder AB | 2,954 | 2.5M SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 2,879 | 276.2K $ | 0.03 % | as of May 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 2,800 | 260.5K $ | 0.10 % | as of Jun 30, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 2,544 | 236.7K $ | 0.06 % | as of Jun 30, 2026 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Echiquier Health Impact for All La Financière de l'Échiquier | 2.55 % | as of Jun 30, 2025 ↗ |
| Edmond de Rothschild Fund - Healthcare Edmond de Rothschild Asset Management (Luxembourg) | 2.31 % | as of Mar 31, 2026 ↗ |
| Echiquier World Equity Growth La Financière de l'Échiquier | 2.23 % | as of Mar 31, 2026 ↗ |
| Carmignac Portfolio Grande Europe Carmignac Gestion Luxembourg S.A. | 1.48 % | as of Dec 31, 2025 ↗ |
| Carmignac Portfolio Patrimoine Europe Carmignac Gestion Luxembourg S.A. | 0.29 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 3.41 % | as of May 31, 2026 ↗ |
| Langar Global Health Tech ETF SPINNAKER ETF SERIES | 2.88 % | as of Jun 30, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 2.63 % | as of Jun 30, 2026 ↗ |
| Echiquier Health Impact for All La Financière de l'Échiquier | 2.55 % | as of Jun 30, 2025 ↗ |
| Edmond de Rothschild Fund - Healthcare Edmond de Rothschild Asset Management (Luxembourg) | 2.31 % | as of Mar 31, 2026 ↗ |
| Echiquier World Equity Growth La Financière de l'Échiquier | 2.23 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 1.94 % | as of Jun 30, 2026 ↗ |
| EUROPE 30 PROFUND ProFunds | 1.86 % | as of Jul 31, 2026 ↗ |
| PROFUND VP EUROPE 30 ProFunds | 1.85 % | as of Jun 30, 2026 ↗ |
| MERCH-EUROUNION, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 1.62 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 121 | -20 | 17,822,647 | -15.4 % |
| 2026Q2 | 141 | +6 | 21,055,737 | +10.9 % |
| 2026Q1 | 135 | -18 | 18,986,471 | -4.0 % |
| 2025Q4 | 153 | -14 | 19,772,784 | +19.0 % |
| 2025Q3 | 167 | +11 | 16,611,285 | +6.6 % |
| 2025Q2 | 156 | -4 | 15,579,722 | +6.1 % |
| 2025Q1 | 160 | +37 | 14,679,590 | +20.3 % |
| 2024Q4 | 123 | +28 | 12,197,517 | +23.4 % |
| 2024Q3 | 95 | +12 | 9,883,719 | -4.6 % |
| 2024Q2 | 83 | 0 | 10,361,530 | +0.2 % |
| 2024Q1 | 83 | -5 | 10,340,942 | +2.0 % |
| 2023Q4 | 88 | 10,136,650 |
Institutional managers
271 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5,856,073 | 520.5K $ | as of Mar 31, 2026 |
| FMR LLC | 5,709,240 | 507.4M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 3,793,711 | 337.2M $ | as of Mar 31, 2026 |
| FLOSSBACH VON STORCH SE | 3,680,315 | 327.1M $ | as of Mar 31, 2026 |
| Dodge & Cox | 3,676,791 | 326.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,658,153 | 147.4M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 1,651,789 | 146.8M $ | as of Mar 31, 2026 |
| Temasek Holdings (Private) Ltd | 1,506,027 | 133.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 951,372 | 84.6M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 903,029 | 80.3M $ | as of Mar 31, 2026 |
| GSK plc | 889,824 | 79.1M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 882,572 | 78.4M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 839,991 | 74.7M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 783,995 | 69.7M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 670,514 | 59.6M $ | as of Mar 31, 2026 |
| Long Focus Capital Management, LLC | 624,000 | 55.5M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 488,367 | 43.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 482,411 | 42.9M $ | as of Mar 31, 2026 |
| DekaBank Deutsche Girozentrale | 481,397 | 42.1K $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 476,923 | 42.4M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 470,000 | 41.8M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 391,689 | 34.8M $ | as of Mar 31, 2026 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 387,214 | 34.4M $ | as of Mar 31, 2026 |
| LBP AM SA | 385,109 | 34.2M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 384,626 | 34.2M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding BioNTech SE". https://titelia.com/en/stocks/biontech-se-US09075V1026